✦ LIBER ✦

Systemic sclerosis: current views of its pathogenesis

✍ Scribed by Chris T Derk; Sergio A Jimenez

Book ID: 114415192
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 320 KB
Volume: 2
Category: Article
ISSN: 1568-9972
DOI: 10.1016/s1568-9972(03)00005-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathogenesis of Progressive Systemic Scl

Pathogenesis of Progressive Systemic Sclerosis

✍ U. F. Haustein; K. Herrmann; H. J. Böhme 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB

Esophageal dysfunction and its pathogene

Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis

✍ Weihrauch, T. R. ;Korting, G. W. ;Ewe, K. ;Vogt, G. 📂 Article 📅 1978 🏛 Springer-Verlag 🌐 English ⚖ 694 KB

The Pathogenesis of Systemic Sclerosis R

The Pathogenesis of Systemic Sclerosis Revisited

✍ Matthias Geyer; Ulf Müller-Ladner 📂 Article 📅 2010 🏛 Humana Press Inc 🌐 English ⚖ 654 KB

Pathogenesis of heart fibrosis in system

Pathogenesis of heart fibrosis in systemic sclerosis

✍ Jiri T. Beranek 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Current views on the pathogenesis of fev

Current views on the pathogenesis of fever

✍ Zoltán Szelényi 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Current therapy of systemic sclerosis (s

Current therapy of systemic sclerosis (scleroderma)

✍ M�ller-Ladner, U. ;Benning, K. ;Lang, B. 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 653 KB

Treatment of systemic sclerosis (scleroderma) presents a challenge to both the patient and the physician. Established approaches include long-term physiotherapy, disease-modifying agents such as D-penicillamine, and treatment of organ involvement. These efforts are often unsatisfactory since the res